Hepatic encephalopathy

被引:9
作者
Srinivasan Dasarathy
Kevin D. Mullen
机构
[1] MetroHealth Medical Center,Gastrointestinal Division, Department of Medicine
关键词
Hepatic Encephalopathy; Transjugular Intrahepatic Portosystemic Shunt; Lactulose; Flumazenil; Main Drug Interaction;
D O I
10.1007/s11938-001-0017-3
中图分类号
学科分类号
摘要
A characteristic feature of the neuropsychiatric changes in hepatic encephalopathy (HE) is the potential for a complete recovery in the majority of patients. In this review, we limit our discussion to HE in individuals with chronic liver disease. The optimal approach to the management of HE includes the following elements.Provide standard supportive therapy for patients with an altered mental status. This is the mainstay of therapy in the majority of clinical situations and includes administration of parenteral fluids and nutrition, care of vascular and bladder catheters, control of self-injurious activities, and instituting aspiration precautions.Rule out or control concomitant causes of encephalopathy. The diagnosis of HE has positive and negative criteria, and ruling out other causes of change in mental status is an essential component of the diagnosis.Identify and correct the precipitating factors of HE. In the majority of patients with HE, a clearly defined precipitating factor usually is identified, and the reversal or control of these factors is a key step in management.Institute gut-cleansing and ammonia-lowering measures. These measures are based on clinical and pathogenic characteristics of HE and are aimed at neutralizing the putative encephalogenic toxins (namely ammonia).
引用
收藏
页码:517 / 526
页数:9
相关论文
共 89 条
[1]  
Adams RD(1949)The neurological changes in the more common types of severe liver disease Trans Am Neurolog Assoc 74 217-219
[2]  
Foley JM(1953)The neurological disorder associated with liver disease Proc Assoc Res Nerv Ment Dis 32 198-237
[3]  
Adams RD(1953)Observations on symptoms and pathogenesis of hepatic coma Quart J Med 20 421-438
[4]  
Foley JM(1954)Portal-systemic encephalopathy: neurological complications of liver disease Lancet 2 453-457
[5]  
Walshe JM(2000)Public health challenges in hepatitis C virus infection J Gastroenterol Hepatol 15 E83-90
[6]  
Sherlock S(1995)Hepatic encephalopathy after portosystemic shunts: any clue from TIPS? Am J Gastroenterol 90 531-533
[7]  
Summerskill WHJ(1996)Pathogenesis of hepatic encephalopathy: potential future approaches Dig Dis 14 20-29
[8]  
White LP(1992)Which portosystemic shunt is best? Gastroenterol Clin North Am 21 179-196
[9]  
Phear EA(1989)Branched chain amino acids in the management of hepatic encephalopathy: an analysis of variants Hepatology 10 228-246
[10]  
Kaldor JM(1970)Precipitating factors in the genesis of hepatic coma N Y State J Med 23 2891-2896